The major CYP11A1-derived hydroxyderivatives can also be metabolized by CYP24A1, which catalyzes their hydroxylation at C24 or C25, and can increase their potency rather than decrease it, at least for inhibition of melanoma cell proliferation [420,461]. This evidence concerns the gene CYP11A1 and melanoma.